Home > News > Company News

2024 API Xi'an

2024-12-19

We have participated in CPHI CHINA 2024 from October 16 to 21, 2024, our booth number is W7B56.


We met and negotiated various API and intermediates business with our customers at the exhibition.


Our company is one of the leading API developers and manufacturers in the global national and multinational pharmaceutical industry. Aims to provide quality services, including the development and export of pharmaceutical APIs, FDF preparations, including gemcitabine hydrochloride, celecoxib, bromhexine hydrochloride, elamod, apremilast, tofacitinib citrate, criborole, urapidil hydrochloride, allicin, dexmedetomidine hydrochloride, rocuronium bromide, finerenone, risedronate sodium, lifalast, difacillin and other raw materials.

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept